Team:UCL/Background

From 2013.igem.org

(Difference between revisions)
Line 60: Line 60:
</div>
</div>
-
             <div class="col_right" style="background-image:url('https://static.igem.org/mediawiki/2013/7/76/Head_poster.jpg');">
+
             <div class="col_right" style="background-image:url('#');">
</div>
</div>
Line 71: Line 71:
<div class="row_small">
<div class="row_small">
-
<div class="col_illustration" style="background-image:url('http://blog.lib.umn.edu/santa013/neuropathology/40xneurocyt.jpg');">
+
<div class="col_illustration" style="background-image:url('#');">
</div>
</div>
Line 91: Line 91:
<div class="row_small">
<div class="row_small">
-
<div class="col_illustration" style="background-image:url('http://www.dxpath.com/histlib/JPGs/20592s.JPG');">
+
<div class="col_illustration" style="background-image:url('#');">
</div>
</div>
Line 110: Line 110:
<div class="row_small">
<div class="row_small">
-
<div class="col_illustration" style="background-image:url('http://biocare.net/wp-content/uploads/290.jpg');">
+
<div class="col_illustration" style="background-image:url('#');">
</div>
</div>

Revision as of 13:02, 29 August 2013

BACKGROUND

Neuro-genetic engineering

Our project this year blends the fields of synthetic biology and neuroscience. We aim to demonstrate that genetic engineering techniques can be applied to the central nervous system, in order to rectify abnormalities in, for example, the brain on a cellular and/or macromolecular level. Such a novel application of synthetic biology could offer new ways to treat certain brain diseases, such as Alzheimer’s disease, for which modern pharmaceutical treatment is purely symptomatic.

Click the abstracts below to read more.